0000899866-19-000025.txt : 20190301 0000899866-19-000025.hdr.sgml : 20190301 20190301163002 ACCESSION NUMBER: 0000899866-19-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190227 FILED AS OF DATE: 20190301 DATE AS OF CHANGE: 20190301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bazarko Daniel CENTRAL INDEX KEY: 0001768214 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 19649835 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS, INC. STREET 2: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 4752302596 MAIL ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: ALEXION PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960111 4 1 wf-form4_155147578795701.xml FORM 4 X0306 4 2019-02-27 0 0000899866 ALEXION PHARMACEUTICALS, INC. ALXN 0001768214 Bazarko Daniel C/O ALEXION PHARMACEUTICALS, INC. 121 SEAPORT BOULEVARD BOSTON MA 02210 0 1 0 0 SVP, Controller, CAO Common Stock, par value $.0001 per share 2019-02-27 4 F 0 70 135.58 D 4737 D This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units. /s/ Douglas Barry, Attorney-in-Fact for Daniel Bazarko 2019-03-01